Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Serum Levels of Selected Cytokines in B-Cell Precursor Acute Lymphoblastic Leukemia and Their Association with Prognostic Factors and Survival

Jan M Horacek, MD PhD, Tomas Kupsa, MD PhD, Jan Vanek, PhD, Ladislav Jebavy, MD PhD, Pavel Zak, MD PhD

Blood (2019) 134 (Supplement_1): 5078.

https://doi.org/10.1182/blood-2019-122667

Published: 2019

Journal Articles

The Influence of FLT3-ITD Mutation on Baseline Levels of Selected Cytokines and Soluble Adhesion Molecules in Acute Myeloid Leukemia with Mutated NPM-1

Tomas Kupsa, MD PhD, Jan M Horacek, MD PhD, Ladislav Jebavy, MD PhD, Pavel Zak, MD PhD

Blood (2019) 134 (Supplement_1): 5111.

https://doi.org/10.1182/blood-2019-126433

Published: 2019

Journal Articles

Impact of Comorbidities and Concomitant Medications on Survival of Patients with Chronic Lymphocytic Leukemia: Analysis of an Unselected Patient Population from East Bohemia

Pavel Vodarek, MD, Denisa Zeberova, Martin Simkovic, MD PhD, Monika Motyckova, MD PhD, David Belada, MD PhD, Pavel Žák, MD PhD, Lukas Smolej, MD PhD

Blood (2017) 130 (Supplement 1): 5328.

https://doi.org/10.1182/blood.V130.Suppl_1.5328.5328

Published: 2017

Journal Articles

Simple Prognostic Score for Evaluation of Elderly Multiple Myeloma Patients

Jakub Radocha, MD PhD, Pavel Zak, MD PhD, Katerina Machalkova, MD, Katerina Beranova, MD, Jiri Hanousek, MD, Vladimír Maisnar, MD PhD

Blood (2016) 128 (22): 5679.

https://doi.org/10.1182/blood.V128.22.5679.5679

Published: 2016

Journal Articles

Serum Levels of Cytokines and Cytokine Receptors Are Associated with Outcome in Newly Diagnosed AML Patients

Tomas Kupsa, MD, Jan Vanek, PhD, Pavel Zak, MD PhD, Ladislav Jebavy, Prof., MD, Jan M. Horacek, MD PhD

Blood (2016) 128 (22): 5246.

https://doi.org/10.1182/blood.V128.22.5246.5246

Published: 2016

Journal Articles

Stem Cell Mobilization after Various Induction Regimens in Patients with Multiple Myeloma

Jakub Radocha, MD PhD, Vladimir Maisnar, MD PhD, Miriam Lanska, MD, Jiri Hanousek, MD, Katerina Machalkova, MD, Katerina Beranova, MD, Alzbeta Zavrelova, MD, Monika Motyckova, MD PhD, Pavel Zak, MD PhD

Blood (2015) 126 (23): 5433.

https://doi.org/10.1182/blood.V126.23.5433.5433

Published: 2015

Journal Articles

The Detection of Viral Infection in Bronchoalveolar Lavage Samples Collected From Recipients of Allogeneic Haematological Stem Cell Transplantation with Pneumonia (A 3 Year Epidemiological Study 2008–2010)

Eva Stepanova, Jr., MD, Pavel Zak, MD, PhD, Alzbeta Zavrelova, MD, Melanie Cermanova, MD, PHD, Jakub Radocha, MD, Lenka Pliskova, Sr., MD, Vlasta Stepanova, MD, Lukas Smolej, M.D., Ph.D.

Blood (2011) 118 (21): 4577.

https://doi.org/10.1182/blood.V118.21.4577.4577

Published: 2011

Journal Articles

Identification of Novel Molecular Markers for the Follow-up of Minimal Residual Disease in Hematooncological Disorders

David Warren Hardekopf, Tereza Jancuskova, Marie Jarosova, Lucie Krutilkova, Radek Plachy, Lenka Zejskova, Radek Cmejla, PhD, Jan Vydra, Tomas Kozak, MD, PhD, Michal Karas, Vladimir Koza, MD, Alzbeta Zavrelova, MD, Pavel Zak, MD, PhD, Lukas Smolej, M.D., Ph.D., Sona Pekova

Blood (2011) 118 (21): 4905.

https://doi.org/10.1182/blood.V118.21.4905.4905

Published: 2011

Journal Articles

Five-Color Multiplex Real-Time PCR Technology to Detect Over 75 Recurrent Chromosomal Abnormalities in Acute Myeloid Leukemia; Benefits for Minimal Residual Disease Detection

Radek Plachy, Lenka Zejskova, Radek Cmejla, PhD, David Warren Hardekopf, Tereza Jancuskova, Lucie Krutilkova, Michal Karas, Vladimir Koza, MD, Jan Vydra, Pavel Zak, MD, PhD, Lukas Smolej, M.D., Ph.D., Sona Pekova

Blood (2011) 118 (21): 2526.

https://doi.org/10.1182/blood.V118.21.2526.2526

Published: 2011

Journal Articles

Decrease of Bone Marrow Fibrosis in Hairy Cell Leukemia (HCL) after 2-CdA Therapy.

Pavel Zak, MD, PhD, Karel Dedic, MD, PhD

Blood (2004) 104 (11): 4574.

https://doi.org/10.1182/blood.V104.11.4574.4574

Published: 2004

NARROW

Serum Levels of Selected Cytokines in B-Cell Precursor Acute Lymphoblastic Leukemia and Their Association with Prognostic Factors and Survival

The Influence of FLT3-ITD Mutation on Baseline Levels of Selected Cytokines and Soluble Adhesion Molecules in Acute Myeloid Leukemia with Mutated NPM-1

Impact of Comorbidities and Concomitant Medications on Survival of Patients with Chronic Lymphocytic Leukemia: Analysis of an Unselected Patient Population from East Bohemia

Simple Prognostic Score for Evaluation of Elderly Multiple Myeloma Patients

Serum Levels of Cytokines and Cytokine Receptors Are Associated with Outcome in Newly Diagnosed AML Patients

Stem Cell Mobilization after Various Induction Regimens in Patients with Multiple Myeloma

The Detection of Viral Infection in Bronchoalveolar Lavage Samples Collected From Recipients of Allogeneic Haematological Stem Cell Transplantation with Pneumonia (A 3 Year Epidemiological Study 2008–2010)

Identification of Novel Molecular Markers for the Follow-up of Minimal Residual Disease in Hematooncological Disorders

Five-Color Multiplex Real-Time PCR Technology to Detect Over 75 Recurrent Chromosomal Abnormalities in Acute Myeloid Leukemia; Benefits for Minimal Residual Disease Detection

Decrease of Bone Marrow Fibrosis in Hairy Cell Leukemia (HCL) after 2-CdA Therapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only